    <!-- NEW INVESTOR-FOCUSED SECTIONS (FEAT-004) -->
    
    <!-- SECTION 1: HERO -->
    <section class="investor-hero" id="investor-hero">
        <div class="investor-container">
            <h1 class="investor-h1">Building the Safety OS™ for the $1 Trillion Humanoid Healthcare Market</h1>
            <div style="text-align: center; margin: 2rem auto;">
                <img src="MAINLOGOPCC.png" alt="PatientCentricCare.AI" style="max-width: 300px; width: 60%; height: auto;">
            </div>
            <p class="investor-subtitle">The first regulatory-grade software platform that will make humanoid robots safe, compliant, and commercially viable for patient care.</p>
            
            <!-- Investor Pitch Video -->
            <div class="investor-video-container">
                <iframe 
                    src="https://www.youtube.com/embed/WwxU1KrYACk" 
                    title="PatientCentricCare.AI Investor Pitch - The $1 Trillion Opportunity"
                    frameborder="0" 
                    allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" 
                    allowfullscreen>
                </iframe>
            </div>
            
            <a href="/investors/" class="investor-cta-button">Enter Investor Data Room</a>
        </div>
    </section>
    
    <!-- SECTION 2: URGENCY -->
    <section id="urgency" class="investor-section">
        <div class="investor-content-card">
            <h2 class="investor-h2">A Global Crisis Meets a Market Inflection Point</h2>
            
            <p class="investor-p">The world faces an unprecedented caregiver crisis. By 2050, <strong>1.6 billion people over 65</strong> will need daily care, but there aren't enough human caregivers to meet demand. Healthcare systems are collapsing under the weight of chronic staffing shortages, burnout, and rising costs.</p>
            
            <p class="investor-p">Meanwhile, <strong>affordable humanoid robots</strong> from companies like Unitree and Boston Dynamics are entering the market at <strong>under $6,000 to $50,000+</strong>—finally making robotic caregivers economically viable for hospitals, nursing homes, and home care.</p>
            
            <p class="investor-p"><strong>But there's a critical problem: No one has solved the safety and regulatory challenge.</strong></p>
        </div>
    </section>
    
    <!-- SECTION 3: RISK -->
    <section id="risk" class="investor-section" style="background: #f8f9fa;">
        <div class="investor-content-card">
            <h2 class="investor-h2">Affordable Home Robots Are About to Be Misused</h2>
            
            <p class="investor-p">Without regulatory-grade safety controls, the humanoid healthcare market faces a <strong>ticking liability time bomb</strong>:</p>
            
            <div class="investor-risk-list">
                <div class="investor-risk-item">
                    <h4>1. Patient Safety Risk</h4>
                    <p>Autonomous robots making critical care decisions without physician oversight could harm vulnerable patients</p>
                </div>
                
                <div class="investor-risk-item">
                    <h4>2. Regulatory Non-Compliance</h4>
                    <p>Off-label use of general-purpose robots for medical tasks violates FDA regulations</p>
                </div>
                
                <div class="investor-risk-item">
                    <h4>3. Liability Exposure</h4>
                    <p>Hospitals and care facilities face massive lawsuits if robots cause patient harm</p>
                </div>
                
                <div class="investor-risk-item">
                    <h4>4. Market Paralysis</h4>
                    <p>Without clear compliance pathways, institutional buyers won't adopt—stalling the entire $1T market</p>
                </div>
            </div>
            
            <p style="text-align: center; font-size: 1.3rem; color: #E67E22; font-weight: 600; margin-top: 2rem;">
                The industry needs a regulatory bridge. That's where we come in.
            </p>
        </div>
    </section>
    
    <!-- END NEW INVESTOR SECTIONS -->
